Flyer

Archives in Cancer Research

  • ISSN: 2254-6081
  • Journal h-index: 14
  • Journal CiteScore: 3.77
  • Journal Impact Factor: 4.09
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • J-Gate
  • Secret Search Engine Labs
  • International Committee of Medical Journal Editors (ICMJE)
  • Zenodo
Share This Page

Transanal minimally invasive rectal surgery

Joint Event on 36th World Cancer Conference & 3rd Edition of International Conference on Colorectal Cancer
October 11-13, 2018 Zurich, Switzerland

Yahya Al-Abed

Colchester Hospital University NHS Foundation Trust, UK

Scientific Tracks Abstracts: Arch Cancer Res

Abstract:

In recent times and with advent of technology, minimally invasive surgery has become the gold standard treatment for colorectal disease. Rectal surgery remains the most challenging and requires adequate training due to the complex anatomy and difficult access. The introduction of the laparoscopic and robotic surgery has improved the transabdominal access to the rectum. Over the past decades, however, the use of transanal endoscopic microsurgery (TEMS) has been limited to some rectal polyps. Recently, the introduction of transanal ports and the transanal minimally invasive surgery (TAMIS), the development of high definition camera systems, 3D technology and 4K screens access to the rectum has improved and this have allowed the introduction of transanal total mesorectal excision (TATME) surgery. Moreover, the indications for minimally invasive rectal surgery have expanded to include the treatment of rectal cancer. The purpose if this presentation is to review the indications, techniques and current evidence of minimally invasive rectal surgery. Recent Publications 1. Eric Rullier, et al. (2017) Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial. Lancet. 390(10093):469-479. 2. Garcia-Aguilar J, et al. (2015) Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncol. 16(15):1537-1546. 3. Rackley T P, et al. (2016) Transanal local excision for patients with rectal cancer: can radiation compensate for what is perceived as a non-definitive surgical approach? Dis Colon Rectum. 59(3):173-8. 4. Borstlap W A, et al. (2016) Meta-analysis of oncological outcomes after local excision of pT1-2 rectal cancer requiring adjuvant (chemo) radiotherapy or completion surgery. Br J Surg. 103(9):1105-16.

Biography :

Yahya Al-Abed is a Consultant Colorectal and Minimally Invasive Surgeon based in London, United Kingdom. He has completed his Surgical Training at University of Edinburgh from London and Colchester and has special interest in minimally invasive surgery. He has contributed to multiple national and international presentations and he is involved in innovation and research.

E-mail: yalabed@yahoo.co.uk